The Annals New | Pharmaco Epidemiology and Therapeutic Risk Management
home help contact us subscription past issues search current issue
QUICK SEARCH:   [advanced]


     


Published Online, 27 April 2004, www.theannals.com, DOI 10.1345/aph.1D571.
 The Annals of Pharmacotherapy: Vol. 38, No. 6, pp. 1024-1030. DOI 10.1345/aph.1D571
© 2004 Harvey Whitney Books Company.
This Article
Right arrow Résumé Freely available
Right arrow Extracto Freely available
Right arrow Full Text
Right arrow PDF
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Articles Ahead of Print
Right arrow [Order Reprint]
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Romanelli, F.
Right arrow Articles by Smith, K. M
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Romanelli, F.
Right arrow Articles by Smith, K. M

HIV/AIDS

Recreational Use of Sildenafil by HIV-Positive and -Negative Homosexual/Bisexual Males

Frank Romanelli, PharmD BCPS

Assistant Professor of Pharmacy, Clinical Specialist in HIV/AIDS, College of Pharmacy, University of Kentucky, Lexington, KY

Kelly M Smith, PharmD

Associate Professor of Pharmacy; Director, Drug Information Center, College of Pharmacy, University of Kentucky

Reprints: Frank Romanelli PharmD BCPS, College of Pharmacy, University of Kentucky, 800 Rose St., Lexington, KY 40536-0082, fax 859/323-0069, froma2{at}uky.edu

OBJECTIVE: To conduct an epidemiologic review of sildenafil in homosexual and bisexual males focusing on concurrent use with club drugs and/or antiretroviral medications.

DATA SOURCES: A search of MEDLINE was conducted (1966–September 2003), and an extensive manual review of journals was performed using the key search terms club drugs, sildenafil, antiretrovirals, and HIV.

STUDY SELECTION AND DATA EXTRACTION: All articles identified from the data sources were evaluated and information deemed relevant was included.

DATA SYNTHESIS: Several epidemiologic studies have reported that sildenafil is abused in a recreational fashion, typically with agents commonly known to be "club drugs." In this setting, sildenafil may reverse the impotence-inducing effects of the club drugs and restore sexual capabilities. Many implications of both recreational and nonrecreational use of sildenafil exist in relation to HIV disease. Concern has been raised regarding the potential effects on high-risk sexual practices. Also, several researchers have documented interactions between sildenafil and various club drugs, as well as with antiretrovirals intended for HIV disease.

CONCLUSIONS: Serious concerns exist regarding the concurrent use of sildenafil with antiretrovirals and/or club drugs. Clinicians prescribing sildenafil to patients receiving protease inhibitor–containing antiretroviral regimens should be aware of the potential for reduced sildenafil metabolism with resultant adverse effects. Additionally, untoward effects may also occur when sildenafil is used concurrently with various club drugs including amyl and butyl nitrites ("poppers").

Key Words: club drugs, HIV, sildenafil

Published Online, April 27, 2004. www.theannals.com, DOI 10.1345/aph.1D571

THIS ARTICLE IS APPROVED FOR CONTINUING EDUCATION CREDIT
ACPE UNIVERSAL PROGRAM NUMBER: 407-000-04-021-H02




homecopy help contact us subscription past issues search current issue
Copyright © 2004 by Harvey Whitney Books Company.